Tumour-derived interleukin I cc (ILmI cc) up-regulates the release of soluble intercellular adhesion molecule-I (sICAM-I) by endothelial cells
1997

Tumour-derived interleukin 1a increases soluble ICAM-1 release by endothelial cells

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): E Fonsatti, M Altomonte, S Coral, I Cattarossi, MR Nicotra, A Gasparollo, PG Natali, M Maio

Primary Institution: Istituto Nazionale di Ricovero e Cura a Carattere Scientifico-Centro di Riferimento Oncologico, Avano, Italy

Hypothesis

Does tumour-derived interleukin 1a (IL-1a) up-regulate the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells?

Conclusion

Tumour-derived IL-1a significantly increases the release of sICAM-1 by human umbilical vein endothelial cells.

Supporting Evidence

  • IL-1a was detectable in conditioned media from HT-1080 and 5637 cells.
  • Endothelial cells showed increased sICAM-1 release when cultured with conditioned media from neoplastic cells.
  • The addition of anti-IL-1a neutralizing antibodies completely abolished the up-regulation of sICAM-1.

Takeaway

When cancer cells release a substance called IL-1a, it makes blood vessel cells release more of a molecule called sICAM-1, which helps cancer cells avoid being attacked by the immune system.

Methodology

The study used conditioned media from seven neoplastic cell lines to assess the effect of IL-1a on sICAM-1 release by human umbilical vein endothelial cells (HUVECs).

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication